Planning for Biological Disasters

Anderson A. , & Eisold J.F. (2002). Anthrax attack at the United States Capitol: Front line thoughts. AAOHN Journal 50(4), 170–173.

Arnon S.S. Schechter R. Inglesby T.V. Henderson D.A. Bartlett J.G. Ascher M.S. Eitzen E. Fine A.D. Hauer J. Layton M. Lillibridge S. Osterholm M.T. O'Toole T. Parker G. Perl T.M. Russell D.L. Swerdlow P.K. , & Tonat K. (2001). Botulism as a biological weapon, medical and public health management. Journal of American Medical Association, 285(8), 1059–1070.

Ashford D.A. Perkins B. Rotz L.D. (2000). Use of anthrax vaccine in the United States. Morbidity and Mortality Weekly Report, 49(RR15), 1–20.

Barbera J. Macintyre A. Gostin J.D. Inglesby T. O'Toole T. DeAtley C. Tonat K. , & Layton M. (2001). Large-scale quarantine following biological terrorism in the Untied States: Scientific examination, logistical and legal limits, and possible consequences. Journal of American Medical Association, 286(21), 2711–2717.

Beaton R. , & Murphy S.A. (2002). Psychological responses to biological and chemical terrorist threats and events: Implications for the workplace and for occupational health nurses. AAOHN Journal, 50(4), 182–189.

Cangemi C.W. (2001). Occupational response to terrorism. AAOHN Journal, 50(4), 190–196.

Center for Civilian Biodefense Studies. (2000a). Anthrax [On-line]. Johns Hopkins University. Available: http://www.hopkins-biode-fense.org/pages/agents/agentanthrax.html.

Center for Civilian Biodefense Studies. (2000b). Botulism [On-line]. Johns Hopkins University. Available: http://www.hopkins-biode-fense.org/pages/agents/agentbotox.html.

Centers for Disease Control and Prevention. (2001a). Notice to readers: Considerations for distinguishing influenza-like illness from inhalational anthrax. Morbidity and Mortality Weekly Report, 50(44), 984–986.

Centers for Disease Control and Prevention. (2001b). Recognition of illness associated with the intentional release of a biological agent. Morbidity and Mortality Weekly Report, 50(41), 893–897.

Centers for Disease Control and Prevention. (2001c). Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy. Morbidity and Mortality Weekly Report, 50(42), 909–919.

Centers for Disease Control and Prevention. (2002, February 20). Disease information, viral hemorrhagic fevers: Fact sheets [On-line]. Available: http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/filoviruses.htm.

DeCarteret J. Hau M. , & Gochnour M.K. (2001). Examples of occupational health and safety programs. In Salazar M.K. (Ed.). Core curriculum for occupational and environmental health nursing (2nd ed.). Philadelphia, PA: W.B. Saunders.

Dennis D.T. Inglesby T.V. Henderson D.A. Bartlett J.G. Ascher M.S. Eitzen E. Fine A.D. Friedlander A.M. Hauer J. Layton M. Lillibridge S.R. McDade J. Osterholm M.T. O'Toole T. Parker G. Perl T.M. Russell P.K. , & Tonat K. (2001). Tularemia as a biological weapon, medical, and public health management. Journal of the American Medical Association, 285(21), 2763–2773.

Dieckhaus K.D. , & Garibaldi R.A. (1998). Occupational infections. In Rom W.N. (Ed.), Environmental & occupational medicine (3rd ed.). Philadelphia: Lippincott-Taven.

Feldman H. , & Klenk H. (2001). Filoviruses. In Baron S. (Ed.), Medical microbiology (4th ed.). Galveston, TX: University of Texas Medical Branch.

Glass T.A. , & Schoch-Spana M. (2002). Bioterrorism and the people: How to vaccinate a city against panic. Clinical Infectious Diseases, 34(2), 217–223.

Gwerder L.J. Beaton R. , & Daniell W. (2001). Bioterrorism: Implications for the occupational and environmental health nurse. AAOHN Journal, 49(11), 512–518.

Henderson D.A. (1999, February 26). The looming threat of bioterrorism. Science, 283(5406), 1279–1282.

Henderson D.A. Inglesby T.V. Bartlett J.G. Ascher M.S. Eitzen E. Jahrling P.B. Hauer J. Layton M. McDade J. Osterholm M.T. O'Toole T. Parker G. Perl T. Russell P.K. , & Tonat K. (1999). Smallpox as a biological weapon, medical and public health management: Working Group on Civilian Biodefense. Journal of the American Medical Association, 281(22), 2127–2137.

Inglesby T.V. Dennis D.T. Henderson D.A. Bartlett J.G. Ascher M.S. Eitzen E. Fine A.D. Friedlander A.M. Hauer J. Koerner J.F. Layton M. McDade J. Osterholm M.T. O'Toole T. Parker G. Perl T.M. Russell P.K. Schoch-Spana M. , & Tonat K. (2000). Plague as a biological weapon, medical and public health management: Working Group on Civilian Biodefense. Journal of the American Medical Association, 283(17), 2281–2290.

Khan A.S. Levitt M.A. , & Sage M.J. (2000). Biological and chemical terrorism: Strategic plan for preparedness and response. Morbidity and Mortality Weekly Report, 49(RR04), 1–14.

Mathias C.T. (1994). Occupational dermatosis. In Zenz C. Dickerson O.B. , & Harvath E.P. (Eds.), Occupational medicine (3rd ed.). St. Louis: Mosby.

O'Toole T. (2001). Emerging illness and bioterrorism: Implications for public health. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 78(2), 396–402.

Pfau C.J. (2001). Arenaviruses. In Baron S. (Ed.), Medical microbiology (4th ed.). Galveston, TX: University of Texas Medical Branch.

Rotz L.D. Dotson D.A. Damon I.K. , & Becher J.A. (2001). Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. Morbidity and Mortality Weekly Report, 50(RR10), 1–25.

World Health Organization. (2001). Smallpox. Weekly epidemiological Record, 76(44), 337–344.